Get the Stockscreener App
14.61
1.08%
-0.16
Surgery Partners Inc stock is traded at $14.61, with a volume of 966.76K.
It is down -1.08% in the last 24 hours and up +4.88% over the past month.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
See More
Previous Close:
$14.77
Open:
$14.86
24h Volume:
966.76K
Relative Volume:
0.72
Market Cap:
$1.91B
Revenue:
$3.34B
Net Income/Loss:
$97.10M
P/E Ratio:
-24.55
EPS:
-0.595
Net Cash Flow:
$208.00M
1W Performance:
+5.18%
1M Performance:
+4.88%
6M Performance:
+8.79%
1Y Performance:
-30.86%
1-Day Range:
$14.51
$14.90
1-Week Range:
$13.68
$15.34
52-Week Range:
$11.41
$23.44
Surgery Partners Inc Stock (SGRY) Company Profile
Name
Surgery Partners Inc
Sector
Industry
Phone
615-234-5900
Address
340 SEVEN SPRINGS WAY, BRENTWOOD, TN
Compare SGRY vs HCA, THC, EHC, DVA, FMS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SGRY
Surgery Partners Inc
|
14.61 | 1.91B | 3.34B | 97.10M | 208.00M | -0.595 |
HCA
Hca Healthcare Inc
|
458.84 | 99.34B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
267.25 | 21.52B | 21.46B | 2.65B | 3.35B | 19.23 |
EHC
Encompass Health Corp
|
127.87 | 12.61B | 6.07B | 793.80M | 464.40M | 5.9914 |
DVA
Davita Inc
|
187.31 | 11.95B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
22.17 | 11.80B | 22.44B | 1.35B | 2.03B | 1.9002 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-18-25 | Resumed | JP Morgan | Neutral |
| Jul-28-25 | Resumed | BofA Securities | Buy |
| Dec-16-24 | Initiated | BofA Securities | Buy |
| Oct-14-24 | Initiated | UBS | Buy |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-28-24 | Initiated | Macquarie | Outperform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Nov-14-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Jun-02-23 | Upgrade | BofA Securities | Neutral → Buy |
| May-12-23 | Initiated | Mizuho | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-23-22 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-15-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-10-22 | Resumed | Citigroup | Buy |
| Nov-30-21 | Initiated | Barclays | Overweight |
| Nov-29-21 | Upgrade | Stifel | Hold → Buy |
| Nov-01-21 | Initiated | JP Morgan | Neutral |
| Oct-18-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Jun-23-21 | Resumed | Stifel | Hold |
| Sep-17-20 | Reiterated | The Benchmark Company | Buy |
| Apr-27-20 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-03-20 | Downgrade | The Benchmark Company | Buy → Hold |
| Jan-14-20 | Reiterated | The Benchmark Company | Buy |
| Nov-16-18 | Initiated | UBS | Neutral |
| Sep-18-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jun-28-18 | Upgrade | Stifel | Sell → Hold |
| Jan-30-18 | Reiterated | The Benchmark Company | Buy |
| Nov-01-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Aug-09-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
| Aug-09-17 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Aug-09-17 | Downgrade | Stifel | Hold → Sell |
| Apr-24-17 | Reiterated | Stifel | Hold |
| Mar-10-17 | Downgrade | Stifel | Buy → Hold |
| Jan-31-17 | Initiated | The Benchmark Company | Buy |
| Jun-10-16 | Initiated | KeyBanc Capital Mkts | Overweight |
| Mar-14-16 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-27-15 | Initiated | Stifel | Buy |
| Oct-26-15 | Initiated | RBC Capital Mkts | Outperform |
| Oct-26-15 | Initiated | Raymond James | Strong Buy |
View All
Surgery Partners Inc Stock (SGRY) Latest News
Surgery Partners (SGRY) Faces Softer Volumes With Fair Value Still Higher - Yahoo Finance
Deals tracker: Harbor Health to buy 27 Village Medical clinics - Modern Healthcare
Why Surgery Partners (SGRY) Is Back In The Spotlight - Simply Wall Street
Cantor Fitzgerald reiterates Surgery Partners stock Overweight rating By Investing.com - Investing.com Australia
Cantor Fitzgerald reiterates Surgery Partners stock Overweight rating - Investing.com
Cantor Fitzgerald reiterates Surgery Partners stock Overweight rating - Investing.com India
Surgery Partners, Inc. (SGRY) Stock Price, News, Quote & History - Yahoo! Finance Canada
Cantor Fitzgerald reiterates Surgery Partners stock rating on volumes By Investing.com - Investing.com South Africa
Cantor Fitzgerald reiterates Surgery Partners stock rating on volumes - Investing.com
Surgery Partners (NasdaqGS:SGRY) Stock Forecast & Analyst Predictions - Simply Wall Street
Wall Street Analysts See a 26.14% Upside in Surgery Partners (SGRY): Can the Stock Really Move This High? - Eastern Progress
A Look at Surgery Partners Inc (SGRY) After 7.8% Decline -- GF V - GuruFocus
Surgery Partners (SGRY) Soars 15.7%: Is Further Upside Left in the Stock? - Zacks Investment Research
Surgery Partners (SGRY) Resets 2026 Outlook On Facility Removal As Valuation Questions Build - simplywall.st
Surgery Partners completes sale of Idaho Falls facilities for $797m - Investing.com Nigeria
Surgery Partners (SGRY) exits Idaho Falls hospitals to cut debt - Stock Titan
Avoiding Lag: Real-Time Signals in (SGRY) Movement - Stock Traders Daily
Surgery Partners (SGRY) Could Be 20% Undervalued Following Its Recent Bounce - simplywall.st
Surgery Partners Inc. (SGRY) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
Surgery Partners Director Teresa DeLuca Buys 11,250 Shares - Yahoo Finance
Surgery Partners Inc (SGRY) Stock Down 4.2% -- Now Undervalued? GF Score: 61/100 - GuruFocus
How Surgery Partners Inc. (SGRY) Affects Rotational Strategy Timing - Stock Traders Daily
Surgery Partners stock gains as investors digest recent rally - ad-hoc-news.de
Surgery Partners stock holds gains as investors await next earnings update - ad-hoc-news.de
Barclays Maintains Surgery Partners(SGRY.US) With Hold Rating, Maintains Target Price $14 - moomoo.com
How Mixed Q2 Results and Slower M&A At Surgery Partners (SGRY) Have Changed Its Investment Story - simplywall.st
Surgery Partners Inc (SGRY) Stock Up 4.2% and Still Undervalued -- GF Score: 63/100 - GuruFocus
Surgery Partners director Teresa DeLuca buys $161,212 in stock By Investing.com - Investing.com Nigeria
Odysight.ai Inc. Announces Closing of $11 million Public Offering of Common Stock - Yahoo Finance
Top insider buys and sells disclosed for Thursday - Investing.com
Surgery (SGRY) EPS and Revenue: EPS Lands Above Forecast; After Earnings: Shares Move Higher 2.50% on the DayEarnings Stability Report - Vinanet
Surgery Partners director Teresa DeLuca buys $161,212 in stock - Investing.com
Surgery Partners director Teresa DeLuca buys $161,212 in stock By Investing.com - Investing.com Canada
Surgery Partners director Teresa DeLuca buys $161,212 in stock - Investing.com
Surgery Partners (SGRY) Insider Teresa Deluca Purchases 10,000 S - GuruFocus
Surgery Partners (SGRY) Stock May Be Undervalued After Q2 Earnings Beat - Yahoo Finance
Surgery Partners Director Teresa DeLuca Acquires 10,000 Shares at $14.35 Each - Kalkine Media
Surgery Partners Earnings Call Highlights Strategic Reset - TipRanks
Does Surgery Partners’ (SGRY) Slower M&A Pace Clarify or Complicate Its ASC-Focused Strategy? - Sahm
Surgery Partners Beats Q2 Estimates, Divests Idaho Falls Hospitals in Strategic Pivot - finance.biggo.com
Surgery Partners (SGRY) Q2 2026 Earnings Call Transcript - The Globe and Mail
Community Health Trades at a Deep Discount to Peers: Hold or Fold? - TradingView
Does Surgery Partners’ (SGRY) Slower M&A Pace Clarify or Complicate Its ASC-Focused Strategy? - simplywall.st
The Top 5 Analyst Questions From Surgery Partners’s Q2 Earnings Call - Yahoo Finance
The Top 5 Analyst Questions From Surgery Partners’s Q2 Earnings Call - theglobeandmail.com
Surgery Partners (SGRY) Reaffirmed Guidance On Revenue Growth, Is It Still A Bargain? - Sahm
Outpatient & Specialty Care Stocks Q2 Highlights: Surgery Partners (NASDAQ:SGRY) - Yahoo Finance
Surgery Partners Inc. (SGRY) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
Surgery Partners Inc. (SGRY) Q1 2026 Earnings ReportResults, Call & Slides - tipranks.com
King Street Capital discloses 4.6% Surgery Partners (SGRY) holding in Schedule 13G - Stock Titan
Surgery Partners Inc Stock (SGRY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Surgery Partners Inc Stock (SGRY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Doherty David T | Chief Financial Officer |
Mar 16 '26 |
Sale |
12.50 |
8,867 |
110,838 |
221,679 |
| David Doherty | Officer |
Mar 16 '26 |
Proposed Sale |
12.50 |
8,867 |
110,843 |
0 |
| Evans Jason Eric | Chief Executive Officer |
Mar 16 '26 |
Sale |
12.47 |
20,400 |
254,388 |
920,386 |
| Jason Eric Evans | Director |
Mar 16 '26 |
Proposed Sale |
12.47 |
20,400 |
254,420 |
0 |
| Brittenham Marissa | Chief Strategy Officer |
Mar 13 '26 |
Sale |
12.54 |
3,657 |
45,859 |
94,196 |
| Burkhalter Danielle | Chief Human Resources Officer |
Mar 13 '26 |
Sale |
12.83 |
3,469 |
44,507 |
76,864 |
| Marissa Brittenham | Officer |
Mar 13 '26 |
Proposed Sale |
12.54 |
3,657 |
45,859 |
0 |
| Danielle Burkhalter | Officer |
Mar 13 '26 |
Proposed Sale |
12.83 |
3,469 |
44,507 |
0 |
| Jennifer Baldock | Officer |
Mar 12 '26 |
Proposed Sale |
13.17 |
5,798 |
76,385 |
0 |
| Baldock Jennifer | Chief Admin & Dev Officer |
Mar 12 '26 |
Sale |
13.17 |
5,798 |
76,360 |
326,474 |
3.21%
1.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):